MedTrace Logo

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

NCT04783701 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2025-12-19

No results posted yet for this study

Summary

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

Conditions

  • Acute Coronary Syndrome
  • Coronary Bypass Stenosis

Sponsors & Collaborators

  • University Hospital, Linkoeping

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2026-02-01
Completion
2026-03-15

Countries

  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04783701 on ClinicalTrials.gov